Theralink Technologies, Inc.
THER · OTC
9/30/2023 | 9/30/2022 | 9/30/2021 | 9/30/2020 | |
|---|---|---|---|---|
| Market Cap | $55 | $206 | $2,685 | $267 |
| - Cash | $997 | $393 | $314 | $1,779 |
| + Debt | $19,762 | $4,375 | $479 | $392 |
| Enterprise Value | $18,820 | $4,187 | $2,850 | -$1,120 |
| Revenue | $607 | $568 | $506 | $181 |
| % Growth | 6.8% | 12.3% | 179% | – |
| Gross Profit | $481 | $343 | $388 | $129 |
| % Margin | 79.2% | 60.4% | 76.8% | 71% |
| EBITDA | -$8,732 | -$11,449 | -$5,380 | -$3,249 |
| % Margin | -1,439.1% | -2,016% | -1,064.1% | -1,792.8% |
| Net Income | -$30,908 | -$12,749 | -$5,593 | -$3,211 |
| % Margin | -5,093.6% | -2,245% | -1,106.2% | -1,772.1% |
| EPS Diluted | -0.005 | -0.002 | -0.001 | -0.001 |
| % Growth | -127.3% | -120% | 23.1% | – |
| Operating Cash Flow | -$5,775 | -$5,390 | -$4,781 | -$3,471 |
| Capital Expenditures | -$163 | -$132 | -$136 | -$532 |
| Free Cash Flow | -$5,938 | -$5,521 | -$4,917 | -$4,002 |